Pulmonx Corp. (LUNG) Social Stream
PULMONX CORP (LUNG) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering LUNG.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-03 | 5 | $65 | $45 | $54.333 | $12 | 352.77% |
| 2021-12-08 | 5 | $65 | $45 | $54.333 | $12 | 352.77% |
| 2022-01-07 | 5 | $65 | $37 | $52.5 | $12 | 337.5% |
| 2022-02-24 | 5 | $60 | $30 | $45 | $12 | 275% |
| 2022-03-01 | 6 | $60 | $28 | $42.571 | $12 | 254.76% |
| 2022-03-31 | 6 | $55 | $28 | $39.666 | $12 | 230.55% |
| 2022-04-11 | 5 | $55 | $28 | $39.666 | $12 | 230.55% |
| 2022-05-04 | 5 | $55 | $28 | $39.166 | $12 | 226.38% |
| 2022-06-09 | 5 | $55 | $23 | $36.857 | $12 | 207.14% |
| 2022-07-18 | 6 | $55 | $19 | $33 | $12 | 175% |
| 2022-08-03 | 6 | $55 | $19 | $28.285 | $12 | 135.71% |
| 2022-10-03 | 6 | $55 | $19 | $27.857 | $12 | 132.14% |
| 2022-10-11 | 6 | $31 | $19 | $23 | $12 | 91.67% |
| 2022-11-04 | 5 | $19 | $13 | $15.666 | $12 | 30.55% |
| 2022-11-14 | 5 | $19 | $8 | $13.833 | $12 | 15.28% |
| 2022-12-12 | 6 | $16 | $8 | $12.333 | $12 | 2.78% |
| 2023-01-03 | 6 | $16 | $6 | $11.428 | $12 | -4.77% |
| 2023-02-08 | 6 | $16 | $6 | $10.785 | $12 | -10.12% |
| 2023-02-24 | 7 | $20 | $6 | $11.857 | $12 | -1.19% |
| 2023-02-26 | 7 | $20 | $6 | $11.857 | $12 | -1.19% |
| 2023-02-27 | 7 | $20 | $8 | $13.142 | $12 | 9.52% |
The Trend in the Analyst Price Target
Over the past 46 weeks, LUNG's average price target has gone down $26.52.
LUNG reports an average of 70.57% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-17 | 5 | 55 | 23 | 36.857 | 18.98 | 94.19% |
| 2022-08-03 | 6 | 55 | 19 | 28.285 | 19.11 | 48.01% |
| 2022-09-10 | 6 | 55 | 19 | 27.857 | 20.35 | 36.89% |
| 2022-10-11 | 6 | 31 | 19 | 23.000 | 14.96 | 53.74% |
| 2023-02-26 | 7 | 20 | 6 | 11.857 | 10.37 | 14.34% |
LUNG Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.71 | 5 | 0 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
LUNG's average broker recommendation rating improved by 0.2 over the prior 39 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for LUNG as an investment opportunity.
- LUNG has a greater upside potential (average analyst target price relative to current price) than 1417.6% of all US stocks.
- LUNG has a lower variance in analysts' estimates than -1618.96% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, PULMONX CORP's number of analysts covering the stock is higher than 723.32% of them.
- In the context of stocks in the mid market cap category, PULMONX CORP's average analyst price target is greater than 880.23% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to PULMONX CORP are NVST, SDC, and EYE.
View All Top Stocks by Price Target
Is LUNG a Buy, Hold or Sell? See the POWR Ratings now!